Skip to main content
. 2018 Aug 27;62(9):e00432-18. doi: 10.1128/AAC.00432-18

FIG 1.

FIG 1

Flow diagram of this study. LR-BAC group, rabeprazole at 10 mg b.i.d. plus bismuth, amoxicillin, and clarithromycin; LR-BAT group, rabeprazole at 10 mg b.i.d plus bismuth, amoxicillin, and tetracycline; HR-BAC group, rabeprazole at 20 mg b.i.d. plus bismuth, amoxicillin, and clarithromycin; HR-BAT group, rabeprazole at 10 mg b.i.d plus bismuth, amoxicillin, and tetracycline. ITT, intention-to-treat; PP, per-protocol.